Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,331 across all filing types
Latest filing 2019-01-07 Investor Presentation
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure to present at investor meetings in San Francisco
Investor Presentation Classification · 98% confidence The document is explicitly titled "Corporate Presentation January 2019" and contains slides detailing company strategy, market position, financial highlights (specifically for the first nine months of 2018), and risk factors. This format is characteristic of an Investor Presentation (IP), which is designed to communicate key information to current and potential investors, often used during roadshows or investor days. It is not a formal regulatory filing like a 10-K, nor is it a brief announcement of a report (RPA). The content is a comprehensive presentation deck.
2019-01-07 English
Photocure to present at investor meetings in San Francisco
Investor Presentation Classification · 95% confidence The document is very short (1044 characters) and announces that management will be presenting at investor meetings in San Francisco in connection with the J.P. Morgan healthcare conference. Crucially, it states, 'Please find the presentation attached: JP Morgan Jan 2019' and provides a link to a PDF presentation. This structure—an announcement about an upcoming event/presentation and attaching/linking the presentation material—fits the definition of an Investor Presentation (IP) being distributed via an announcement, or more precisely, the announcement itself regarding the presentation materials. Since the text is primarily an announcement about presenting and attaching the presentation material, it aligns best with the Investor Presentation (IP) category, as it is the material being shared with investors, even if distributed via a short regulatory-style announcement. If the document were only announcing the *intent* to present without attaching the material, RPA might be considered, but here the presentation material link is provided.
2019-01-07 English
Photocure to present at Nordic-American Life Science Conference in New York
Regulatory Filings Classification · 95% confidence The document is a short announcement dated November 29, 2018, stating that Photocure will be presenting at a conference in New York. It mentions the presentation will be made available on the company's website afterward. The text is promotional/informational regarding an event, not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed investor presentation (IP). Since it is an announcement about an event where information will be shared, and it doesn't fit the specific categories like AGM-R, ER, or IP, it falls best under the general category for regulatory announcements or news releases that don't fit elsewhere, which is RNS (Regulatory Filings). Given the very short length and the nature of announcing an event/presentation, it is not the presentation itself (IP) or a formal financial report.
2018-11-29 English
Photocure to present at Nordic-American Life Science Conference in New York
Report Publication Announcement Classification · 99% confidence The document is a short press release announcing that the CEO of Photocure ASA will be presenting at a life science conference in New York. It provides details about the presentation time and states that the presentation materials will be made available on the company's website afterward. Since the document itself is an announcement about an event and the subsequent availability of presentation materials, and it does not contain the full presentation content, it fits best as a general regulatory announcement or news release. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate announcement that doesn't fit a specific financial reporting category (like ER, 10-K, or IP). It is too brief and lacks the substance of an Investor Presentation (IP) or Earnings Release (ER).
2018-11-29 English
Photocure ASA - Share capital increase registered
Share Issue/Capital Change Classification · 98% confidence The document explicitly states 'Share capital increase registered' and details the resulting change in the total number of shares and the share capital amount (NOK 10,889,504 divided on 21,779,008 shares). This directly relates to a change in the company's capital structure through the issuance of new shares under a share option program. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). The document length is very short (768 chars), but the content is a direct announcement of a capital change, not just an announcement *about* a report, making SHA more specific than RPA or RNS.
2018-11-26 English
Photocure ASA: Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Photocure ASA: Mandatory notification of trade' and details a purchase of shares by a 'primary insider' (Ambaw Bellete). This transaction involves a director/executive trading in the company's stock, which directly corresponds to the definition of Director's Dealing (insider trades). The filing type code for this is DIRS.
2018-11-26 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.